Affiliations 

  • 1 Department of Nephrology, Queensland Children's Hospital, Brisbane, Queensland, Australia
  • 2 Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA
  • 3 Academic Nephrology Unit, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK
  • 4 Division of Healthcare Delivery Science & Innovation, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
  • 5 IIS-Fundacion Jimenez Diaz UAM, RICORS2040, Madrid, Spain
  • 6 Vanderbilt University Medical Center, Nashville, TN, USA
  • 7 Department of Internal Medicine IV, Renal and Hypertensive Disease & Transplant Centre, Saarland University Medical Centre, Homburg, Germany
  • 8 Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina School of Medicine, Chapel Hill, NC, USA
  • 9 European Renal Association, Parma, Italy
  • 10 Division of Nephrology and Endocrinology, Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan
  • 11 Department of Clinical Research and Epidemiology, Renal Research Unit, University Hospital of Würzburg, Würzburg, Germany
  • 12 International Society of Nephrology, Brussels, Belgium
  • 13 Department of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana
  • 14 Department of Nephrology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia
  • 15 Instituto de Nefrologia Pergamino, Pergamino City, Argentina
  • 16 Centro de Hemodiálisis Crónica CASMU-IAMPP, Montevideo, Uruguay
  • 17 Renal Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Enugu State, Nigeria
  • 18 George Institute for Global Health, University of New South Wales, New Delhi, India. vjha@georgeinstitute.org.in
Nat Rev Nephrol, 2024 Apr 03.
PMID: 38570631 DOI: 10.1038/s41581-024-00820-6

Abstract

Early detection is a key strategy to prevent kidney disease, its progression and related complications, but numerous studies show that awareness of kidney disease at the population level is low. Therefore, increasing knowledge and implementing sustainable solutions for early detection of kidney disease are public health priorities. Economic and epidemiological data underscore why kidney disease should be placed on the global public health agenda - kidney disease prevalence is increasing globally and it is now the seventh leading risk factor for mortality worldwide. Moreover, demographic trends, the obesity epidemic and the sequelae of climate change are all likely to increase kidney disease prevalence further, with serious implications for survival, quality of life and health care spending worldwide. Importantly, the burden of kidney disease is highest among historically disadvantaged populations that often have limited access to optimal kidney disease therapies, which greatly contributes to current socioeconomic disparities in health outcomes. This joint statement from the International Society of Nephrology, European Renal Association and American Society of Nephrology, supported by three other regional nephrology societies, advocates for the inclusion of kidney disease in the current WHO statement on major non-communicable disease drivers of premature mortality.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.